top of page

US FDA approves AstraZeneca's breast cancer drug combination

The U.S. Food and Drug Administration on Thursday approved AstraZeneca's (AZN.L) Truqap in combination with an older drug, providing another treatment option for patients with the most common type of breast cancer.




Comentários


Featured Posts
Recent Posts
Archive
Search By Tags
bottom of page